COREY HEICHEL: Open Payments
NPI 1134319601 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 92 payments from 14 companies in 2025. Trend: 2023 $222 · 2024 $2,244 · 2025 $2,001
Food & beverage: $2,001
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $405 |
| ABBVIE INC. | 19 | $396 |
| Amgen Inc. | 14 | $224 |
| GENZYME CORPORATION | 3 | $200 |
| E.R. Squibb & Sons, L.L.C. | 9 | $161 |
| Lilly USA, LLC | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| PFIZER INC. | 5 | $103 |
| Janssen Biotech, Inc. | 4 | $95 |
| Mallinckrodt Hospital Products Inc. | 3 | $55 |
Products named: Bimzelx, RINVOQ, KEVZARA, SKYRIZI, ORENCIA, TALTZ, COSENTYX, XELJANZ.
Industry payments across FL — which companies pay providers there.
